 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
A short sqeeze in Harvard Scientific (HVSF). Ha, Ha. Here's the chance all small-cap longs have waited for. Rumor (:-)) has it that there has been major short selling (up to 1mm shares) in HVSF by folks who thought they had stock available as a result of an upcoming note conversion with the company. Problem seems to be the time for conversion is (NOT) 40 days as assumed, but the note is convertable in 1 yr. Appears they may have sold stock they don't have. Anyway, that's all rumor. P.S. read the news releases from company and look at the recent volume on way down. Anyway, the stock was recently recommended by Kostek- story to follow. If you see stock starting up, the sqeeze will be on. That's a lot of shares to cover with very little stock available. Price could easly move into the $4 range in very short period. Medium term, company has THE best pecker hardner medicine (period) on market and expects to put major pressure on Upjohn's market leading injection (needle in the dick) approach. UpJohn has done all its scientific DD on HVSF's patented technology, and one could resonably speculate that Upjohn would elect to buy out company at some price north of $10-12/s within next six to eight months. In Feb, independent biotech advisory svc. had a projection of $26-28 within 24 months as technology completed testing and company sales and market share increased. As HVSF completes its Phase II & III testing, the price will keep keep going up. This is a neat story and immediate play for the intrepid. Report to follow on next message. Good luck. Gm | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |